Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

PURPOSE: The association of deficient DNA mismatch repair (dMMR) with prognosis in patients with colon cancer treated with adjuvant fluorouracil, leucovorin, and oxaliplatin (FOLFOX) chemotherapy remains unknown. PATIENTS AND METHODS: Resected, stage III colon carcinomas from patients (N = 2,686) ra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sinicrope, Frank A., Mahoney, Michelle R., Smyrk, Thomas C., Thibodeau, Stephen N., Warren, Robert S., Bertagnolli, Monica M., Nelson, Garth D., Goldberg, Richard M., Sargent, Daniel J., Alberts, Steven R.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2013
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3789216/
https://ncbi.nlm.nih.gov/pubmed/24019539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.48.9591
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars